Company: BBVXF
Filing Date: 2025-09-05
Form Type: F-4/A
Source: 0001193125-25-196513
Chunk: 132

Company: BANCO BILBAO VIZCAYA ARGENTARIA, S.A.
Filing Date: 2025-09-05
Form: F-4/A
Chunk 132
---
 Group’s Loan-to-Deposit(Ltd.) ratio at 93.2% as at 2024 year-end (94.0% as at 2023 year-end). 2023 The information in this subsection has been extracted from page 97 of Banco Sabadell’s consolidated financial statements as of and for the year ended December 31, 2023, reproduced herein on page A-413. See also Note 4.4.3.1 to the consolidated financial statements as of and for the year ended December 31, 2023. Due to rising interest rates in the financial markets, the weight of term deposits and other deposits in the composition of on-balancesheet customer funds has increased. Details of off-balancesheet customer funds managed by the Group and those sold but not under management are provided in Note 27. The Group’s deposits are sold through the business units/companies of the Group (Banking Business Spain, TSB and Mexico). In 2023, the funding gap has widened, with a sharper decline in lending than in customer funds, thus placing the Group’s Loan-to-Deposit(LtD) ratio at 94.0% as at 2023 year-end (95.6% as at 2022 year-end). 101

Capital Markets The information in this subsection has been extracted from page 29 of Banco Sabadell’s condensed consolidated interim financial statements as of and for the six months ended June 30, 2025, reproduced herein on page A-29. See also Schedule III to the condensed consolidated interim financial statements as of and for the six months ended June 30, 2025. The level of funding in capital markets has remained stable and the Institution has a buffer comfortably above the Minimum Requirement for own funds and Eligible Liabilities (MREL). During the first half of the year, Banco Sabadell issued three deals on the wholesale market in the amount of €2 billion and TSB issued an additional deal in the amount of €600 million, managing the respective maturities in the capital markets. The outstanding nominal balance of the Group’s funding in capital markets, by type of product, as at June 30, 2025 and December 31, 2024 is shown below:

|                                            |     | 6/30/2025  |        |     | 12/31/2024 |        |
|                                            |     | -€ million |        |     |            |        |
| Outstanding nominal balance